Literature DB >> 1328069

Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.

S M Game1, A Huelsen, V Patel, M Donnelly, W A Yeudall, A Stone, N E Fusenig, S S Prime.   

Abstract

This study examined the response of human keratinocytes in different stages of transformation to exogenous TGF-beta 1 and EGF as well as their receptor and growth-factor expression. Cells of the spontaneously immortalized HaCaT cell line and c-Ha-ras transfected clones (I-6, I-7, II-3, II-4) exhibited different tumorigenic potentials when transplanted to athymic mice. HaCaT- and I-6 cells were non-tumorigenic, I-7 cells formed persisting epidermal cysts (benign tumours) and II-3 and II-4 cells developed into invasive squamous-cell carcinomas. TGF-beta 1 inhibited thymidine uptake in a dose-dependent manner, a progressive decrease in response being associated with an increasing malignant potential (HaCaT greater than I-6 greater than I-7 = II-4). HaCaT-cells and ras-clones expressed TGF-beta 1 mRNA at similar levels, but cells of increasing malignant potential secreted markedly less receptor-binding TGF-beta (HaCaT greater than I-6 = I-7 greater than II-3 greater than II-4) into the culture medium. Whilst ras-transfected cells expressed fewer TGF-beta receptors than HaCaT cells, there was little difference between TGF-beta receptor number or affinity between the 4 transfected cell clones. The same was true for the TGF-beta receptor types, but Type-II receptors were expressed at lower levels by the malignant clones II-3 and II-4. When HaCaT and ras-transfected cells were investigated for their response to exogenous EGF, cells were refractory (I-7, II-4), partially stimulated (I-6) or fully stimulated (HaCaT). Cells with increasing malignant potential produced increasing amounts of endogenous TGF-alpha (II-4 = II-3 greater than I-7 = I-6 greater than HaCaT). All tumorigenic ras clones expressed higher mRNA levels than HaCaT-cells. Ras-transfected clones expressed fewer high- and low-affinity EGF receptors than HaCaT cells with a tendency toward increased numbers of high-affinity EGF receptors associated with increasing malignant potential (II-4 = II-3 greater than I-7 greater than I-6) but these changes were associated with a progressive decrease in receptor affinity. The results indicate that tumour progression in human epidermal keratinocytes transfected with c-Ha-ras is associated with a progressive abrogation of TGF-beta 1 and EGF growth control. They suggest that the increased autonomous growth potential associated with advanced stages of epithelial tumour progression can be defined more closely using a cellular profile of TGF-beta and EGF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328069     DOI: 10.1002/ijc.2910520322

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Induction of apoptosis in human HaCaT keratinocytes.

Authors:  U Henseleit; T Rosenbach; G Kolde
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

2.  Regulation of keratinocyte signaling and function via changes in epidermal growth factor presentation.

Authors:  Tracy J Puccinelli; Paul J Bertics; Kristyn S Masters
Journal:  Acta Biomater       Date:  2010-04-14       Impact factor: 8.947

3.  Expression of epidermal growth factor receptor in gestational trophoblastic diseases.

Authors:  P Balaram; M John; T N Rajalekshmy; B Nair; G Schultz; K Nair
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Immobilized epidermal growth factor stimulates persistent, directed keratinocyte migration via activation of PLCγ1.

Authors:  Chloe S Kim; Isaiah P Mitchell; Anthony W Desotell; Pamela K Kreeger; Kristyn S Masters
Journal:  FASEB J       Date:  2016-03-29       Impact factor: 5.191

5.  Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition.

Authors:  Cindy L Kanies; J Joshua Smith; Christian Kis; Carl Schmidt; Shawn Levy; Khalid S A Khabar; Jason Morrow; Natasha Deane; Dan A Dixon; R Daniel Beauchamp
Journal:  Mol Cancer Res       Date:  2008-07       Impact factor: 5.852

6.  Differential expression of matrix metalloproteinases in activated c-ras-Ha-transfected immortalized human keratinocytes.

Authors:  L C Meade-Tollin; P Boukamp; N E Fusenig; C P Bowen; T C Tsang; G T Bowden
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

7.  Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.

Authors:  S S Prime; S M Game; J B Matthews; A Stone; M J Donnelly; W A Yeudall; V Patel; R Sposto; A Silverthorne; C Scully
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

8.  Leader cell PLCγ1 activation during keratinocyte collective migration is induced by EGFR localization and clustering.

Authors:  Chloe S Kim; Xinhai Yang; Sarah Jacobsen; Kristyn S Masters; Pamela K Kreeger
Journal:  Bioeng Transl Med       Date:  2019-06-26

9.  Effects of transforming growth factor beta-1 on growth-regulatory genes in tumour-derived human oral keratinocytes.

Authors:  I C Paterson; V Patel; J R Sandy; S S Prime; W A Yeudall
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

10.  Dysregulation of autocrine TGF-beta isoform production and ligand responses in human tumour-derived and Ha-ras-transfected keratinocytes and fibroblasts.

Authors:  M S Fahey; I C Paterson; A Stone; A J Collier; Y L Heung; M Davies; V Patel; E K Parkinson; S S Prime
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.